Precisely engineering a dual-drug cooperative nanoassembly for proteasome inhibition-potentiated photodynamic therapy DOI

Fujun Yang,

Qingyu Ji,

Rui Liao

et al.

Chinese Chemical Letters, Journal Year: 2021, Volume and Issue: 33(4), P. 1927 - 1932

Published: Nov. 24, 2021

Language: Английский

RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy DOI
Ying Hao, Yuwen Chen, Xinlong He

et al.

Biomaterials, Journal Year: 2022, Volume and Issue: 293, P. 121975 - 121975

Published: Dec. 20, 2022

Language: Английский

Citations

61

Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment DOI Creative Commons
Tian Liu, Lingxiao Li, Shuo Wang

et al.

Nature Communications, Journal Year: 2022, Volume and Issue: 13(1)

Published: Nov. 24, 2022

Abstract Sulfur bonds, especially trisulfide bond, have been found to ameliorate the self-assembly stability of homodimeric prodrug nanoassemblies and could trigger sensitive reduction-responsive release active drugs. However, antitumor efficacy with single reduction-responsivity may be restricted due heterogeneous tumor redox microenvironment. Herein, we replace middle sulfur atom bond an oxidizing tellurium or selenium construct dual-responsive sulfur-tellurium-sulfur sulfur-selenium-sulfur hybrid chalcogen bonds. The exhibit ultrahigh dual-responsivity both oxidation reduction conditions, which effectively address Moreover, promotes prodrugs by providing strong intermolecular forces sufficient steric hindrance. above advantages bridged result in improved docetaxel satisfactory safety. exploration bonds drug delivery deepened insight into development prodrug-based chemotherapy heterogeneity, thus enriching design theory nanomedicines.

Language: Английский

Citations

52

Degradable polyprodrugs: design and therapeutic efficiency DOI
Farzad Seidi,

Yajie Zhong,

Huining Xiao

et al.

Chemical Society Reviews, Journal Year: 2022, Volume and Issue: 51(15), P. 6652 - 6703

Published: Jan. 1, 2022

Degradable polyprodrugs are developed to increase therapeutic properties of drugs and reduce detrimental side effects.

Language: Английский

Citations

51

Emerging small molecule-engineered hybrid nanomedicines for cancer therapy DOI
Yao Chen, Tongyao Zhao,

Meiyu Bai

et al.

Chemical Engineering Journal, Journal Year: 2022, Volume and Issue: 435, P. 135160 - 135160

Published: Feb. 9, 2022

Language: Английский

Citations

49

Recent Progress in Carrier‐Free Nanomedicine for Tumor Phototherapy DOI
Yingtao Zhong, Yi Cen, Lin Xu

et al.

Advanced Healthcare Materials, Journal Year: 2022, Volume and Issue: 12(4)

Published: Nov. 9, 2022

Abstract Safe and effective strategies are urgently needed to fight against the life‐threatening diseases of various cancers. However, traditional therapeutic modalities, such as radiotherapy, chemotherapy surgery, exhibit suboptimal efficacy for malignant tumors owing serious side effects, drug resistance even relapse. Phototherapies, including photodynamic therapy (PDT) photothermal (PTT), emerging localized tumor inhibition, which can produce a large amount reactive oxygen species (ROS) or elevate temperature initiate cell death by non‐invasive irradiation. In consideration poor bioavailability phototherapy agents (PTAs), lots delivery systems have been developed enhance targeted delivery. Nevertheless, carriers inevitably bring biosafety concerns on account their metabolism, degradation, accumulation. Of note, carrier‐free nanomedicine attracts great attention clinical translation with synergistic antitumor effect, is characterized high loading, simplified synthetic method good biocompatibility. this review, latest advances nanomedicines summarized, may provide new paradigm future development precision therapy.

Language: Английский

Citations

49

Lymph node-targeting nanovaccines for cancer immunotherapy DOI
Qiu Wang, Zhe Wang, Xinxin Sun

et al.

Journal of Controlled Release, Journal Year: 2022, Volume and Issue: 351, P. 102 - 122

Published: Sept. 20, 2022

Language: Английский

Citations

46

The dual role of DNA repair protein MGMT in cancer prevention and treatment DOI

Peiying Bai,

Tengjiao Fan, Guohui Sun

et al.

DNA repair, Journal Year: 2023, Volume and Issue: 123, P. 103449 - 103449

Published: Jan. 14, 2023

Language: Английский

Citations

35

Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics DOI Creative Commons

Qing Pei,

Bowen Jiang,

Dengyuan Hao

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2023, Volume and Issue: 13(8), P. 3252 - 3276

Published: March 5, 2023

Chemotherapy has occupied the critical position in cancer therapy, especially towards post-operative, advanced, recurrent, and metastatic tumors. Paclitaxel (PTX)-based formulations have been widely used clinical practice, while therapeutic effect is far from satisfied due to off-target toxicity drug resistance. The caseless multi-components make preparation technology complicated aggravate concerns with excipients-associated toxicity. self-assembled PTX nanoparticles possess a high content could incorporate various functional molecules for enhancing index. In this work, we summarize self-assembly strategy diverse nanodrugs of PTX. Then, advancement tumor emphasis on mono-chemotherapy, combinational theranostics, outlined. Finally, challenges potential improvements briefly spotlighted.

Language: Английский

Citations

29

Ce6 nanoassemblies: Molecular mechanism and strategies for combinational anticancer therapy DOI Creative Commons
Yuwei Liu, Shuting Xu,

Qingyang Lyu

et al.

Aggregate, Journal Year: 2023, Volume and Issue: 5(1)

Published: Oct. 12, 2023

Abstract Nowadays, cancer has become the leading cause of death worldwide, driving need for effective therapeutics to improve patient prognosis. Photodynamic therapy (PDT) been widely applied as an antitumor modality, owing its minimal invasiveness, localized tumor damage, and high safety profile. However, efficacy is limited by poor stability photosensitizers, inadequate accumulation, a complex microenvironment. To overcome these challenges, extensive endeavors have made explore co‐assembly used photosensitizer chlorin e6 (Ce6) with various functional small molecules enhance pharmacodynamic activity. This review provides comprehensive overview current studies on Ce6‐based nanoparticles PDT precise delivery molecules. The self‐assembly mechanism will be discussed in detail, focus potential strategies combinational PDT.

Language: Английский

Citations

25

Carbon-Spaced Tandem-Disulfide Bond Bridge Design Addresses Limitations of Homodimer Prodrug Nanoassemblies: Enhancing Both Stability and Activatability DOI
Hao Zhang, Tian Liu,

Yitong Sun

et al.

Journal of the American Chemical Society, Journal Year: 2024, Volume and Issue: 146(32), P. 22675 - 22688

Published: Aug. 1, 2024

Redox-responsive homodimer prodrug nanoassemblies (RHPNs) have emerged as a significant technology for overcoming chemotherapeutical limitations due to their high drug-loading capacity, low excipient-associated toxicity, and straightforward preparation method. Previous studies indicated that α-position disulfide bond bridged RHPNs exhibited rapid drug release rates but unsatisfactory assembly stability. In contrast, γ-disulfide showed better stability rates. Therefore, designing chemical linkages ensure both stable remains challenging. To address this paradox of in RHPNs, we developed carbon-spaced double-disulfide (CSDD)-bridged (CSDD-RHPNs) with two carbon-spaces. Pilot CSDD-RHPNs carbon-spaces enhanced stability, reduction-responsive release, improved selective toxicity compared α-/γ-position single RHPNs. Based on these findings, four six were designed further investigate the properties CSDD-RHPNs. These excellent ability, safety, prolonged circulation. Particularly, displayed best antitumor efficacy 4T1 B16–F10 tumor-bearing mice. CSDD offer novel perspectives rational design potentially regarding contradictory ability rate.

Language: Английский

Citations

9